A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) – AGMT_CMML-1.

Burgstaller, S, Stauder, R, Kuehr, T, Lang, A, Machherndl-Spandl, S, Mayrbaeurl, B, Noesslinger, T, Petzer, A, Valent, P, Greil, R, Thaler, J.

https://www.ncbi.nlm.nih.gov/pubmed/28853315